herp
simplex
virus
ubiquit
caus
lifelong
infect
human
host
hsv
infect
primarili
acquir
mucos
surfac
initi
epitheli
cell
infect
lead
diseas
manifest
includ
herp
labiali
genit
herp
gingivostomat
herpet
whitlow
enceph
asept
mening
neonat
herp
stromal
kerat
share
common
structur
featur
includ
larg
doublestrand
dna
genom
protect
nucleocapsid
tegument
layer
contain
viral
protein
deliv
host
cell
earli
infect
envelop
deriv
host
membran
stud
viral
glycoprotein
facilit
attach
entri
host
cell
similar
share
nucleotid
ident
lytic
hsv
infect
cell
begin
initi
attach
neg
charg
cell
surfac
heparan
sulfat
chondroitin
sulfat
glycosaminoglycan
follow
stabl
attach
viral
glycoprotein
cell
surfac
receptor
fusion
viral
envelop
plasma
membran
intern
membran
fusion
viral
host
membran
enabl
deliveri
viral
nucleocapsid
tegument
protein
cytoplasm
hsv
nucleocapsid
arriv
nucleu
deliv
viral
genom
hsv
gene
express
order
tempor
cascad
viral
egress
requir
primari
envelop
genomecontain
capsid
inner
nuclear
membran
fusion
outer
nuclear
membran
final
envelop
transgolgi
network
matur
virion
exit
cellular
secretori
system
stage
hsv
replic
cycl
offer
potenti
target
directact
antivir
daa
therapi
howev
daa
undermin
emerg
drug
resist
mutant
virus
antihsv
daa
acyclovir
foscarnet
offer
exampl
hazard
drug
resist
drug
interrupt
hsv
genom
replic
differ
mechan
action
acyclovir
nucleosid
analogu
prodrug
select
target
hsv
infect
cell
action
hsv
thymidin
kinas
tk
enzym
effici
phosphoryl
acyclovir
facilit
incorpor
nascent
viral
dna
genom
hsv
dna
polymeras
enzym
incorpor
acyclovir
viral
dna
termin
genom
replic
contrast
pyrophosph
analogu
foscarnet
block
viral
genom
replic
directli
inhibit
hsv
dna
polymeras
activ
though
resist
acyclovir
occur
low
preval
immunocompet
patient
immunocompromis
patient
experi
much
higher
rate
unsurprisingli
resist
acyclovir
deriv
foscarnet
map
mutat
viral
thymidin
kinas
dna
polymeras
catalyt
subunit
respect
current
abreva
ndocosanol
overthecount
topic
antivir
herp
labiali
abreva
incorpor
cellular
plasma
membran
prevent
fusion
step
essenti
entri
epitheli
cell
howev
must
appli
repeatedli
throughout
day
due
rapid
plasma
membran
turnov
subsequ
loss
ndocosanol
hosttarget
antivir
mechan
prevent
develop
viral
resist
abreva
approv
perior
lesion
still
gap
treatment
lesion
area
bodi
like
abreva
potenti
broadlyact
antivir
drug
exploit
physic
structur
hsv
virion
block
earli
stage
infect
attach
penetr
studi
explor
potenti
plantderiv
photosensit
agent
orthoquintm
mediat
photodynam
inactiv
pdi
virion
clinic
util
orthoquin
pdi
oral
biofilm
area
activ
investig
clear
potenti
wider
rang
clinic
applic
basi
pdi
photodynam
effect
exploit
photodynam
therapi
pdt
treatment
cancer
agerel
macular
degener
pdt
photosensit
compound
expos
visibl
light
react
oxygen
gener
reactiv
oxygen
speci
ro
includ
singlet
oxygen
ro
damag
protein
nucleic
acid
lipid
lead
cell
death
wellknown
photosensit
molecul
pdt
base
tetrapyrrol
core
found
natur
occur
pigment
heme
chlorophyl
bacteriochlorophyl
accept
phototox
mechan
type
photosensit
involv
format
excit
triplet
state
upon
light
absorpt
particip
electron
type
energi
type
transfer
process
type
electron
transfer
reaction
typic
lead
format
radic
speci
like
superoxid
hydroxyl
radic
wherea
type
energi
transfer
produc
cytotox
singlet
oxygen
possibl
photosensit
initi
type
photoprocess
simultan
depend
specif
chemistri
photosensit
agent
environ
due
high
reactiv
short
lifetim
oxid
molecul
expect
viral
structur
close
proxim
activ
photosensit
compound
affect
orthoquin
shown
bacteriocid
properti
disrupt
bacteri
biofilm
without
caus
overt
inflamm
studi
investig
orthoquin
antiherpesvir
properti
mechan
action
show
subcytotox
dose
orthoquin
reduc
plaqu
format
lightdepend
manner
wherea
high
dose
display
lightindepend
antivir
effect
surprisingli
display
high
intrins
photosensit
focus
primarili
rel
photoresist
pdi
requir
close
proxim
orthoquin
viral
inoculum
wherea
pretreat
target
host
cell
orthoquin
expos
light
effect
high
dose
orthoquin
disrupt
immunodetect
subset
structur
protein
polyclon
antibodi
suggest
pdi
may
caus
physic
damag
protein
virion
exterior
prevent
infect
final
demonstr
lightdepend
orthoquin
pdi
adenoviru
infect
lightindepend
inhibit
vesicular
stomat
viru
vsv
infect
hplc
analysi
perform
agilenthewlettpackard
seri
instrument
chemstat
rev
softwar
santa
clara
ca
usa
equip
uvvi
detector
separ
achiev
hypersil
gold
waltham
usa
reversedphas
column
ab
gradient
formic
acid
b
meoh
report
retent
time
correct
within
min
column
temperatur
record
flow
rate
ml
use
inject
volum
sampl
prepar
mg
absorb
valu
sampl
record
nm
nm
nm
nm
nm
constitu
give
rise
largest
signal
wavelength
identifi
analyz
panel
commerci
standard
condit
also
method
standard
addit
largest
signal
wavelength
due
polydatin
resveratrol
anthraglycosid
b
rhein
emodin
physcion
hela
vero
african
green
monkey
kidney
cell
cultur
dulbecco
modifi
eagl
medium
dmem
hyclon
logan
ut
usa
supplement
fetal
bovin
serum
fb
life
technolog
carlsbad
ca
usa
uml
penicillin
streptomycin
mm
lglutamin
life
technolog
htertimmort
human
foreskin
fibroblast
tertbj
gift
dr
william
hahn
danafarb
cancer
institut
boston
usa
cell
maintain
blend
dmem
modifi
eagl
life
technolog
fb
mm
lglutamin
cell
maintain
atmospher
use
strain
strain
inoculum
gener
infect
monolay
vero
cell
low
moi
harvest
cellassoci
viru
three
day
postinfect
briefli
cell
dissoci
plastic
pipet
separ
supernat
centrifug
cell
pellet
resuspend
serumfre
media
lyse
three
cycl
lysat
sonic
probe
sonic
ice
cellular
debri
remov
centrifug
supernat
aliquot
frozen
vsvgfp
gift
dr
roy
duncan
dalhousi
univers
halifax
ns
canada
similarli
grown
vero
cell
isol
supernat
cell
debri
remov
centrifug
use
gfpadenoviru
vector
advgfp
clontech
san
diego
ca
usa
viru
lack
essenti
earli
gene
complement
tran
gener
viru
cell
orthoquin
provid
photodynam
inc
lot
halifax
ns
canada
hela
htertbj
cell
seed
plate
cell
per
well
respect
duplic
plate
follow
day
cell
treat
dilut
orthoquin
equival
dmso
concentr
triplic
h
orthoquin
treatment
plate
place
cm
w
led
lamp
min
room
temperatur
dark
plate
wrap
aluminum
foil
return
incub
total
fluenc
deliv
lighttreat
plate
j
rate
mw
h
incub
alamarblu
ad
well
plate
place
back
incub
h
fluoresc
record
use
tecan
san
jose
ca
usa
infinit
pro
micropl
reader
exem
nm
normal
equival
concentr
dmso
phototox
concentr
cell
line
calcul
use
prism
graph
pad
la
jolla
ca
usa
nonlinear
fit
log
inhibitor
vs
respons
variabl
slope
four
paramet
unless
otherwis
state
orthoquin
viru
prepar
control
pipet
clear
light
vwr
black
dark
argo
technolog
vernon
hill
il
usa
ml
polypropylen
microcentrifug
tube
place
side
w
visibl
led
lamp
cm
bulb
min
room
temperatur
j
mw
vsv
inocula
expos
light
min
photosensit
temperatur
inoculum
light
condit
exceed
hela
cell
seed
densiti
cellsml
cluster
dish
follow
day
medium
remov
cell
inocul
pditreat
mocktreat
serumfre
media
h
shake
everi
min
adapt
avicel
microcrystallin
cellulos
overlay
first
use
plaqu
influenza
plaqu
infect
inoculum
rins
ml
pb
avicel
gift
fmc
biopolym
catalogu
philadelphia
pa
usa
overlay
avicel
mem
supplement
fb
pipet
well
cell
left
plaqu
four
day
postinfect
avicel
overlay
remov
two
pb
wash
cell
fix
stain
ml
crystal
violet
solut
methanol
water
per
well
fixingstain
min
crystal
violet
rins
water
plaqu
imag
use
chemidoc
touch
biorad
hercul
ca
usa
count
use
fiji
distribut
imagej
nih
vero
cell
seed
densiti
cellsml
plate
follow
day
media
remov
cell
inocul
pdi
mocktreat
vsv
serumfre
media
h
shake
everi
min
inoculum
rins
ml
pb
ml
avicel
overlay
avicel
mem
supplement
fb
pipet
well
cell
left
plaqu
one
day
postinfect
avicel
overlay
remov
two
pb
wash
cell
fix
stain
ml
crystal
violet
solut
methanol
water
per
well
describ
plaqu
visual
count
eye
cell
seed
densiti
cellsml
plate
follow
day
medium
remov
cell
inocul
pdi
mocktreat
advgfp
serumfre
medium
h
shake
everi
min
inoculum
rins
ml
pb
ml
prewarm
agaros
overlay
agaros
complet
media
pipet
well
cell
incub
eight
day
postinfect
allow
develop
visibl
plaqu
gfp
plaqu
visual
count
use
fluoresc
microscop
viral
dna
extract
inoculum
use
dneasi
blood
tissu
kit
qiagen
hilden
germani
alter
protocol
briefli
pb
ad
tube
follow
dnase
mgml
sigma
st
loui
mo
usa
sampl
incub
min
buffer
al
kit
master
mix
made
combin
per
sampl
buffer
al
salmon
sperm
dna
invitrogen
carlsbad
ca
usa
carrier
dna
pg
luciferas
vector
normal
recoveri
incub
proteinas
k
buffer
al
master
mix
ad
sampl
sampl
mix
vortex
incub
min
result
mixtur
process
accord
manufactur
instruct
quantit
pcr
perform
use
gotaq
qpcr
master
mix
promega
madison
wi
usa
reaction
follow
manufactur
instruct
use
primer
amplifi
viral
gene
spikedin
plasmid
sampl
run
duplic
biorad
cfx
connect
thermal
cycler
follow
twostep
protocol
min
cycl
melt
curv
complet
read
everi
product
specif
determin
singl
pcr
melt
peak
data
analyz
use
method
gene
express
normal
luciferas
plasmid
express
fold
chang
dark
sampl
hela
cell
seed
dish
mock
infect
infect
moi
left
dmem
contain
fb
h
extracellular
viru
obtain
follow
modifi
version
viru
purif
protocol
publish
loret
et
al
briefli
cell
cultur
supernat
mock
infect
cell
centrifug
g
min
remov
cell
larg
debri
sampl
treat
dnase
min
ice
follow
two
sequenti
centrifug
step
g
min
pellet
materi
resuspend
serumfre
dmem
extracellular
viru
titer
determin
via
plaqu
assay
hela
cell
overlaid
dmem
contain
human
serum
penicillin
streptomycin
lglutamin
approxim
pfu
extracellular
equival
volum
mock
sampl
dilut
serumfre
dmem
left
untreat
treat
vehicl
control
dmso
treat
indic
concentr
orthoquin
incub
light
dark
indic
section
light
exposur
laemmli
buffer
ad
sampl
boil
prior
sdspage
immunoblot
pvdf
membran
block
use
trisbuff
salin
contain
tween
tbst
skim
milk
incub
either
rabbit
antihsv
antibodi
abcam
cambridg
usa
antirabbit
hrplink
secondari
antibodi
cell
signal
danver
usa
rabbit
conjug
antibodi
cell
signal
antibodi
dilut
tbst
contain
skim
milk
blot
develop
use
clariti
western
ecl
blot
substrat
biorad
protein
visual
use
chemidoc
imag
system
biorad
normal
data
manag
perform
microsoft
excel
mac
microsoft
version
redmond
wa
usa
signific
statist
differ
light
dark
treatment
determin
twoway
anova
sidak
multipl
comparison
test
use
prism
graphpad
la
jolla
ca
usa
pvalu
depict
graph
asterisk
orthoquin
plantderiv
natur
product
extract
root
polygonum
cuspidatum
perenni
plant
speci
known
spread
rhizom
reddishbrown
stem
petiol
leav
white
flower
droop
panicl
particular
root
variou
extract
offici
list
chines
pharmacopoeia
use
tradit
chines
medicin
treat
varieti
maladi
polygonum
cuspidatum
thought
origin
china
later
migrat
japan
today
found
throughout
north
america
view
invas
speci
often
refer
japanes
knotwe
prepar
orthoquin
use
present
studi
deriv
polygonum
cuspidatum
root
harvest
nova
scotia
canada
briefli
root
wash
remov
excess
soil
dri
chip
dri
extract
ethanol
room
temperatur
sever
week
ethanol
solut
contain
extract
concentr
vacuo
give
bioactiv
product
enrich
proprietari
fraction
process
final
product
character
hplc
figur
base
uvvi
absorpt
signal
five
differ
wavelength
nm
nm
nm
nm
nm
largest
identifi
signal
base
refer
standard
due
polydatin
resveratrol
anthraglycosid
b
rhein
emodin
physcion
alamarblu
cell
viabil
assay
perform
identifi
phototox
threshold
concentr
orthoquin
transform
hela
epitheli
cell
nonneoplast
immort
htertbj
fibroblast
cell
cell
treat
orthoquin
vehicl
control
follow
exposur
light
sham
dark
treatment
min
room
temperatur
phototox
concentr
orthoquin
hela
htertbj
cell
respect
substanti
dark
cytotox
concentr
rang
test
figur
concentr
lower
orthoquin
use
subsequ
infect
experi
except
note
figur
fall
well
valu
cell
line
test
orthoquin
pdi
prepar
first
expos
light
determin
baselin
level
photosensit
inocula
expos
light
min
use
infect
monolay
hela
cell
plaqu
assay
plaqu
format
significantli
impair
due
exposur
light
figur
b
howev
mark
decreas
plaqu
format
observ
min
light
exposur
plaqu
format
almost
complet
inhibit
min
light
exposur
figur
light
alon
littl
effect
investig
effect
orthoquin
pdi
viral
replic
predominantli
infect
model
antivir
activ
orthoquin
assess
subcytotox
concentr
incolula
mix
indic
concentr
orthoquin
expos
light
min
min
respect
signific
lightdepend
reduct
plaqu
format
observ
dose
orthoquin
dose
orthoquin
figur
howev
dose
orthoquin
potent
inhibit
infect
lightindepend
manner
togeth
find
indic
orthoquin
posess
lightdepend
antihsv
properti
well
lightindepend
properti
oper
higher
concentr
like
longer
light
exposur
time
use
enhanc
orthoquin
antivir
effect
dose
rel
concentr
test
orthoquin
longer
min
due
inher
light
sensit
analyz
antivir
activ
orthoquin
four
dilut
virion
stock
rang
mix
orthoquin
sampl
either
treat
light
kept
dark
expos
expos
light
subsequ
dilut
prior
inocul
hela
cell
monolay
plaqu
assay
lightactiv
orthoquin
treatment
reduc
plaqu
across
three
dilut
ineffect
highest
titer
inoculum
figur
find
indic
orthoquin
pdi
inactiv
across
rang
inoculum
titer
fail
inactiv
highlyconcentr
inoculum
confirm
antivir
effect
orthoquin
due
pdi
effect
virion
plaqu
assay
three
differ
orthoquin
treatment
perform
orthoquin
expos
light
combin
incolula
infect
hela
monolay
treatment
would
allow
us
determin
whether
orthoquin
antivir
activ
due
photoproduct
act
pdi
ii
orthoquin
expos
light
treat
hela
cell
monolay
h
rins
inocul
cell
monolay
treatment
would
allow
us
test
whether
photoproduct
orthoquin
prime
lightindepend
antivir
respons
cell
inocul
iii
orthoquin
mix
expos
light
follow
infect
hela
monolay
figur
figur
expect
orthoquinmedi
antivir
pdi
treatment
ii
reduc
plaqu
format
wherea
iii
effect
reduc
plaqu
format
lightdepend
manner
figur
find
confirm
orthoquin
exert
antivir
activ
pdi
requir
close
proxim
orthoquin
target
virion
light
exposur
orthoquin
pdi
known
produc
ro
could
physic
disrupt
structur
compon
virion
includ
envelop
glycoprotein
lipid
capsid
protein
nucleic
acid
determin
whether
orthoquin
pdi
inhibit
caus
capsid
damag
four
dilut
virion
stock
treat
orthoquin
expos
light
incub
dnase
dna
extract
viral
gene
amplifi
qpcr
capsid
compromis
orthoquin
treatment
amplif
viral
dna
would
expect
dnase
penetratr
capsid
would
degrad
viral
dna
differ
viral
gene
amplif
observ
dilut
indic
assay
reliabl
amplifi
viral
dna
figur
within
dilut
signific
differ
viral
gene
amplif
observ
light
dark
treatment
indic
orthoquin
treatment
compromis
capsid
integr
previou
report
pdi
herpesvirus
suggest
defect
cell
adsorpt
entri
requir
intact
envelop
glycoprotein
determin
whether
orthoquin
pdi
disrupt
glycoprotein
isol
extracellular
viral
particl
differenti
centrifug
treat
effect
dose
use
figur
figur
figur
figur
mgml
orthoquin
vitro
min
presenc
light
prior
process
sampl
sdspage
immunoblot
antibodi
detect
glycoprotein
abcam
inc
technic
support
immunoblot
crude
hela
cell
lysat
confirm
detect
divers
antigen
also
clearli
evid
viral
particl
sampl
indic
repres
structur
protein
figur
pattern
detect
protein
speci
viral
particl
sampl
unchang
treatment
orthoquin
contrast
treatment
higher
mgml
dose
orthoquin
caus
dramat
loss
detect
certain
antigen
kda
rang
lightdepend
manner
know
whether
loss
antigen
detect
due
orthoquin
pdimedi
degrad
select
protein
physic
disrupt
discret
antigen
site
mechan
mgml
dose
far
exce
effect
dose
previous
establish
figur
nevertheless
find
suggest
orthoquin
pdi
physic
disrupt
structur
protein
modest
physic
disrupt
structur
protein
ie
envelop
glycoprotein
treatment
orthoquin
may
suffici
inhibit
infect
without
caus
gross
chang
structur
protein
would
detect
immunoblot
experi
determin
whether
orthoquin
inactiv
virus
attempt
pdi
vesicular
stomat
viru
vsv
envelop
viru
famili
rhabdovirida
human
adenoviru
adv
nonenvelop
viru
famili
adenovirida
vsv
adv
inocula
incub
orthoquin
clear
opaqu
black
tube
follow
infect
target
host
cell
sharp
decreas
vsv
plaqu
observ
start
orthoquin
light
exposur
improv
antivir
activ
concentr
figur
b
contrast
signific
lightdepend
reduct
adv
plaqu
format
observ
start
orthoquin
figur
thu
orthoquin
display
antivir
activ
virus
adv
rel
resist
orthoquin
compar
inactiv
vsv
may
involv
lightindepend
mechan
action
orthoquin
botan
extract
antibacteri
properti
amplifi
light
exposur
consist
past
pdi
studi
differ
photosensit
agent
show
orthoquin
inhibit
infect
lightdepend
manner
surprisingli
photosensit
test
reveal
high
baselin
photosensit
almost
complet
inhibit
plaqu
format
min
light
exposur
contrast
rel
photoresist
reason
focus
mechanist
studi
show
pdi
requir
coadministr
orthoquin
light
viral
inoculum
wherea
preexposur
target
cell
monolay
orthoquin
light
effect
dose
use
studi
consist
known
properti
photosensit
agent
gener
shortliv
ro
singlet
oxygen
damag
nearbi
macromolecul
like
protein
lipid
nucleic
acid
indic
pdi
requir
close
proxim
target
antivir
effect
improv
understand
properti
orthoquin
inform
futur
investig
mechan
virion
damag
orthoquin
contain
two
compound
previous
report
antivir
activ
resveratrol
emodin
resveratrol
inhibit
multipl
envelop
nonenvelop
virus
modul
signal
transduct
pathway
review
emodin
observ
inhibit
human
cytomegaloviru
hepat
b
viru
influenza
viru
iav
human
immunodefici
viru
type
replic
emodin
also
shown
suppress
effici
reactiv
viru
latenc
poliovirusinduc
cytopath
effect
sever
acut
respiratori
syndrom
coronaviru
spike
protein
attach
alkalin
exonucleas
activ
one
known
function
emodin
act
competit
inhibitor
casein
kinas
ii
cellular
kinas
play
key
support
role
mani
viral
infect
addit
highli
hydrophob
anthraquinon
emodin
invad
phospholipid
bilay
promot
nonlamellar
phase
transit
data
demonstr
orthoquin
display
maxim
inhibitori
activ
close
proxim
envelop
virion
prior
infect
rais
possibl
emodininduc
phase
chang
viral
envelop
concomit
pdi
unabl
pinpoint
molecular
target
orthoquin
pdi
virion
studi
high
dose
photoactiv
orthoquin
prevent
polyclon
antibodi
detect
certain
structur
protein
compon
purifi
virion
antibodi
detect
major
glycoprotein
antigen
suggest
orthoquin
pdigener
ro
may
physic
disrupt
antigen
prevent
detect
alter
protein
mobil
sdspage
andor
acceler
protein
degrad
inde
anoth
anthraquinon
deriv
relat
emodin
hypericin
shown
induc
protein
crosslink
vitro
singlet
oxygen
product
follow
photactiv
data
demonstr
presenc
crosslink
viral
protein
orthoquintr
virion
would
nevertheless
interest
investig
chang
virion
protein
molecular
level
studi
also
suggest
orthoquin
pdi
leav
underli
nucleocapsid
intact
viral
dsdna
genom
content
unchang
treat
inoculum
compar
untreat
control
attempt
identifi
specif
glycoprotein
disrupt
orthoquin
pdi
perform
addit
immunoblot
experi
antibodi
rais
glycoprotein
c
howev
experi
inconclus
antibodi
sensit
enough
detect
glycoprotein
c
purifi
virion
prepar
lipid
bilay
compris
hsv
envelop
potenti
target
pdi
test
orthoquin
addit
envelop
viru
vsv
nonenvelop
viru
adv
vsv
suscept
orthoquin
lightindepend
manner
suggest
potenti
distinct
mechan
action
contrast
adv
suscept
orthoquin
light
dosedepend
manner
slightli
less
sensit
previou
research
show
emodin
inactiv
envelop
virus
herpesvirus
japanes
enceph
viru
iav
effect
nonenvelop
virus
adv
serotyp
rhinoviru
serotyp
howev
studi
lin
et
al
emodin
inhibit
enteroviru
replic
stimul
interferon
product
similarli
resveratrol
shown
inhibit
iav
replic
stimul
interferon
product
adv
lack
lipid
envelop
maxim
inhibit
presenc
light
specul
orthoquin
interfer
function
surfaceexpos
viral
protein
howev
exclud
potenti
role
interferon
orthoquin
antivir
activ
time
acyclovir
commonli
use
hsv
antivir
though
resist
acyclovir
clinic
insignific
otherwis
healthi
individu
immunosuppress
individu
much
higher
incid
preval
resist
strongli
link
degre
immunosuppress
durat
acyclovir
exposur
issu
highlight
import
role
hosttarget
broadlyact
antivir
could
play
treatment
drugresist
hsv
infect
research
requir
determin
precis
antihsv
mechan
action
orthoquin
orthoquin
contain
multipl
known
antivir
molecul
may
directli
inactiv
virion
inoculum
via
pdi
disrupt
downstream
intracellular
step
viral
infect
well
specul
orthoquin
may
provid
viabl
broadlyact
altern
inactiv
hsv
surfac
lesion
may
effect
current
drugresist
strain
mitig
emerg
resist
